Volume 8 Issue 155
Published - 14:00 UTC 08:00 EST 5-Jun-2006 
Next Update - 14:00 UTC 08:00 EST 6-Jun-2006

Editor: Susan K. Boyer, RN
All rights reserved.

HONcode accreditation seal. We subscribe to the HONcode principles.
Verify here



Tumor response may not be best measure of efficacy in non-small cell lung cancer treatment

Researchers typically evaluate the effectiveness of a new cancer treatment by looking at how tumors respond to it. But in the case of advanced non-small cell lung cancer, there may be a better way to assess effectiveness. more  

Newborn screening can cause unnecessary parental stress

Virtually all babies in the U.S. have their heels pricked soon after birth to get a blood sample for genetic testing. These "heel stick" tests identify rare metabolic disorders before they cause irreversible damage, but as more disorders are added to the screening many states now test for 30 or more false-positive results are on the rise. In the June issue of Pediatrics, researchers from Children's Hospital Boston report that false-positive results cause considerable parental stress, even when the baby proves negative on retesting, and that the stress could be alleviated by better education for parents and pediatricians. more

Early results find activity in drug that turns on tumor 'death' receptors

The first clinical trial to evaluate a new type of drug that activates "death" receptors on cancer cells has found it to be both safe and suggestive of potential benefit, say researchers from The University of Texas M. D. Anderson Cancer Center. more  

Study of obesity in prostate cancer screening uncovers new predictor of disease for overweight men

Recent studies suggest that testing blood for prostate specific antigen (PSA) alone does not produce an ideal predictor of prostate cancer, and emerging data suggest this is especially true for obese men. A recent study by Oregon Health & Science University Cancer Institute researchers shows that a simple adjustment in how clinical measurements are interpreted in the diagnosis of prostate cancer can accurately predict the presence of prostate cancer in obese men. more

Unfavourable blood fat levels predict rheumatoid arthritis up to 10 years later 

An unfavourable ratio of blood fats could herald the development of the inflammatory joint disease rheumatoid arthritis up to 10 years later, suggests research published ahead of print in the Annals of Rheumatic Diseases. more

Breathing exercises can significantly cut inhaler use in mild asthma  

Breathing techniques can cut the use of reliever inhalers by more than 80% and halve the dose of preventer inhaler required in mild asthma, finds research published ahead of print in Thorax. more

Three-drug regimen improves survival in advanced head and neck cancers

The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination, researchers from Dana-Farber Cancer Institute in Boston will report at the American Society of Clinical Oncology's annual meeting in Atlanta. more


Virtually all babies in the U.S. have their heels pricked soon after birth to get a blood sample for genetic testing.